<code id='61475CFF5B'></code><style id='61475CFF5B'></style>
    • <acronym id='61475CFF5B'></acronym>
      <center id='61475CFF5B'><center id='61475CFF5B'><tfoot id='61475CFF5B'></tfoot></center><abbr id='61475CFF5B'><dir id='61475CFF5B'><tfoot id='61475CFF5B'></tfoot><noframes id='61475CFF5B'>

    • <optgroup id='61475CFF5B'><strike id='61475CFF5B'><sup id='61475CFF5B'></sup></strike><code id='61475CFF5B'></code></optgroup>
        1. <b id='61475CFF5B'><label id='61475CFF5B'><select id='61475CFF5B'><dt id='61475CFF5B'><span id='61475CFF5B'></span></dt></select></label></b><u id='61475CFF5B'></u>
          <i id='61475CFF5B'><strike id='61475CFF5B'><tt id='61475CFF5B'><pre id='61475CFF5B'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:52
          Nasdaq
          Mark Lennihan/AP

          The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

          Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

          advertisement

          Acelyrin’s share price fell more than 60% in after-hours trading Monday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Microsoft launches AI tool for clinical documentation through Epic
          Microsoft launches AI tool for clinical documentation through Epic

          NuanceImageGalleryMicrosoftonThursdaysaiditwilllaunchitsartificialintelligencetoolforautomatingclini

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Dog Aging Project founders on what lies ahead after losing funding

          CelebratingabirthdayatHappyBarkDay,thefirstdogcafeintheGulfemirateofDubai.KARIMSAHIB/AFPviaGettyImag